Skip to main content
Caplight Logo









Inbiome

Inbiome

Private
AmsterdamHealthcare & Life Scienceshttps://inbiome.com/

Last Round

Series A

Apr 1, 2026

Total Funding Raised

$16M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Inbiome is a biotechnology company that has developed a patented Molecular Culture technology, which uses machine learning and chemistry for rapid bacterial diagnostics and microbiome analysis.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Precision Medicine

Business Model

B2B

Customer Profile

Usage-Based SaaS, Services & Consulting

AI Layer

Application

Keywords

bacterial diagnosticsmicrobiome analysisrapid pathogen identificationPCR diagnosticsmolecular diagnosticsclinical diagnosticsAI diagnosticsprecision medicinesepsis diagnosticsantimicrobial resistancemedtechbiotechIVDRpoint of care testingrapid testing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Inbiome Comparables

Compare Inbiome with similar companies based on industry and business-model similarity.

Inbiome comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
OCEAN Dx
78%
Pattern Bioscience
77%
bioMérieux
69%

Inbiome Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AApr 1, 2026
GrantJan 11, 2023

Key People

Founding team and executive leadership

Dries Budding

CEO

Executive Team

Inbiome Investors

Notable investors and investment history

Inbiome investors
InvestorRounds
European Innovation Council FundGrant
Slingshot VenturesSeries A
NATO Innovation FundSeries A
Voima VenturesSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 1, 2026

    $16M round completed.

  • Jan 22, 2026

    Monthly visitors grew 789% MoM, reaching 7.5K.

Inbiome Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Inbiome Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Inbiome's valuation, stock price, and market status.

Firmographic Details

HeadquartersAmsterdam
Employee Range27
Year Founded2019
Last FundingApr 1, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?